???pagination.result.count???
???pagination.result.page???
1
Cannabinoid receptor type 1 regulates sequential stages of migration and morphogenesis of neural crest cells and derivatives in chicken and frog embryos. , Mahomed A, Girn D, Pattani A, Wells BK, King CC, Patel S, Kaur H, Noravian CM, Sieminski J, Pham C, Dante H, Ezin M, Elul T ., J Morphol. July 1, 2023; 284 (7): e21606.
Cell-autonomous and differential endocannabinoid signaling impacts the development of presynaptic retinal ganglion cell axon connectivity in vivo. , Del Rio R, Serrano RG, Gomez E, Martinez JC, Edward MA, Santos RA, Diaz KS, Cohen-Cory S ., Front Synaptic Neurosci. January 1, 2023; 15 1176864.
Normal development in Xenopus laevis: A complementary staging table for the skull based on cartilage and bone. , MacKenzie EM, Atkins JB, Korneisel DE, Cantelon AS, McKinnell IW, Maddin HC ., Dev Dyn. August 1, 2022; 251 (8): 1340-1356.
Involvement of spinal G-protein inwardly rectifying potassium (GIRK) channels in the enhanced antinociceptive effects of the activation of both μ-opioid and cannabinoid CB1 receptors. , Takemura Y, Sudo Y, Saeki T, Kurata S, Suzuki T, Mori T , Uezono Y., J Pharmacol Sci. July 1, 2022; 149 (3): 85-92.
Direct Regulation of Hyperpolarization-Activated Cyclic-Nucleotide Gated (HCN1) Channels by Cannabinoids. , Mayar S, Memarpoor-Yazdi M, Makky A, Eslami Sarokhalil R, D'Avanzo N., Front Mol Neurosci. April 6, 2022; 15 848540.
Cannabinoid Receptor Type 1 regulates growth cone filopodia and axon dispersion in the optic tract of Xenopus laevis tadpoles. , Elul T , Lim J, Hanton K, Lui A, Jones K, Chen G, Chong C, Dao S, Rawat R., Eur J Neurosci. February 1, 2022; 55 (4): 989-1001.
WIN55,212-2, a Dual Modulator of Cannabinoid Receptors and G Protein-Coupled Inward Rectifier Potassium Channels. , An D, Peigneur S, Tytgat J., Biomedicines. April 28, 2021; 9 (5):
Investigation of non- CB1, non-CB2 WIN55212-2-sensitive G-protein-coupled receptors in the brains of mammals, birds, and amphibians. , Breivogel CS, McPartland JM, Parekh B., J Recept Signal Transduct Res. August 1, 2018; 38 (4): 316-326.
The Peptide PnPP-19, a Spider Toxin Derivative, Activates μ-Opioid Receptors and Modulates Calcium Channels. , Freitas ACN, Peigneur S, Macedo FHP, Menezes-Filho JE, Millns P, Medeiros LF, Arruda MA, Cruz J, Holliday ND, Tytgat J, Hathway G, de Lima ME., Toxins (Basel). January 15, 2018; 10 (1):
The Cannabinoid Receptor Interacting Proteins 1 of zebrafish are not required for morphological development, viability or fertility. , Fin L, Bergamin G, Steiner RA, Hughes SM ., Sci Rep. July 7, 2017; 7 (1): 4858.
Endocannabinoid signaling enhances visual responses through modulation of intracellular chloride levels in retinal ganglion cells. , Miraucourt LS, Tsui J , Gobert D, Desjardins JF, Schohl A , Sild M, Spratt P, Castonguay A, De Koninck Y, Marsh-Armstrong N , Wiseman PW, Ruthazer ES ., Elife. August 8, 2016; 5
An endocannabinoid system is present in the mouse olfactory epithelium but does not modulate olfaction. , Hutch CR, Hillard CJ, Jia C, Hegg CC., Neuroscience. August 6, 2015; 300 539-53.
cnrip1 is a regulator of eye and neural development in Xenopus laevis. , Zheng X, Suzuki T, Takahashi C , Nishida E , Kusakabe M ., Genes Cells. April 1, 2015; 20 (4): 324-39.
The cannabinoid CB1 receptor antagonists rimonabant (SR141716) and AM251 directly potentiate GABA(A) receptors. , Baur R, Gertsch J, Sigel E., Br J Pharmacol. April 1, 2012; 165 (8): 2479-84.
Psychotropic and nonpsychotropic cannabis derivatives inhibit human 5-HT(3A) receptors through a receptor desensitization-dependent mechanism. , Xiong W, Koo BN, Morton R, Zhang L., Neuroscience. June 16, 2011; 184 28-37.
Endocannabinoid modulation in the olfactory epithelium. , Breunig E, Czesnik D, Piscitelli F, Di Marzo V, Manzini I , Schild D., Results Probl Cell Differ. January 1, 2010; 52 139-45.
About a snail, a toad, and rodents: animal models for adaptation research. , Roubos EW , Jenks BG , Xu L, Kuribara M, Scheenen WJ, Kozicz T., Front Endocrinol (Lausanne). January 1, 2010; 1 4.
mu-Opioid receptor forms a functional heterodimer with cannabinoid CB1 receptor: electrophysiological and FRET assay analysis. , Hojo M, Sudo Y, Ando Y, Minami K, Takada M, Matsubara T, Kanaide M, Taniyama K, Sumikawa K, Uezono Y., J Pharmacol Sci. November 1, 2008; 108 (3): 308-19.
Endocannabinoids affect the reproductive functions in teleosts and amphibians. , Cottone E, Guastalla A, Mackie K, Franzoni MF., Mol Cell Endocrinol. April 16, 2008; 286 (1-2 Suppl 1): S41-5.
The cannabinoid receptor agonists, anandamide and WIN 55,212-2, do not directly affect mu opioid receptors expressed in Xenopus oocytes. , Kracke GR, Stoneking SP, Ball JM, Tilghman BM, Washington CC, Hotaling KA, Johnson JO, Tobias JD., Naunyn Schmiedebergs Arch Pharmacol. December 1, 2007; 376 (4): 285-93.
Cannabinoid action in the olfactory epithelium. , Czesnik D, Schild D, Kuduz J, Manzini I ., Proc Natl Acad Sci U S A. February 20, 2007; 104 (8): 2967-72.
Xenopus fibrillin regulates directed convergence and extension. , Skoglund P , Keller R ., Dev Biol. January 15, 2007; 301 (2): 404-16.
Endocannabinoid system in Xenopus laevis development: CB1 receptor dynamics. , Migliarini B, Beatrice M, Marucci G, Gabriella M, Ghelfi F, Francesca G, Carnevali O, Oliana C., FEBS Lett. April 3, 2006; 580 (8): 1941-5.
Delta9-tetrahydrocannabinol and endogenous cannabinoid anandamide directly potentiate the function of glycine receptors. , Hejazi N, Zhou C , Oz M, Sun H, Ye JH, Zhang L., Mol Pharmacol. March 1, 2006; 69 (3): 991-7.
Neuroanatomical distribution of cannabinoid receptor gene expression in the brain of the rough-skinned newt, Taricha granulosa. , Hollis DM, Coddington EJ, Moore FL., Brain Behav Evol. January 1, 2006; 67 (3): 135-49.
Structural mimicry in class A G protein-coupled receptor rotamer toggle switches: the importance of the F3.36(201)/W6.48(357) interaction in cannabinoid CB1 receptor activation. , McAllister SD, Hurst DP, Barnett-Norris J, Lynch D, Reggio PH, Abood ME., J Biol Chem. November 12, 2004; 279 (46): 48024-37.
Identification of a potent and highly efficacious, yet slowly desensitizing CB1 cannabinoid receptor agonist. , Luk T, Jin W, Zvonok A, Lu D, Lin XZ, Chavkin C, Makriyannis A, Mackie K., Br J Pharmacol. June 1, 2004; 142 (3): 495-500.
Xenopus laevis CB1 cannabinoid receptor: molecular cloning and mRNA distribution in the central nervous system. , Cottone E, Salio C, Conrath M, Franzoni MF., J Comp Neurol. September 29, 2003; 464 (4): 487-96.
The endogenous cannabinoid anandamide inhibits alpha7 nicotinic acetylcholine receptor-mediated responses in Xenopus oocytes. , Oz M, Ravindran A, Diaz-Ruiz O, Zhang L, Morales M., J Pharmacol Exp Ther. September 1, 2003; 306 (3): 1003-10.
Endogenous cannabinoid, anandamide, acts as a noncompetitive inhibitor on 5-HT3 receptor-mediated responses in Xenopus oocytes. , Oz M, Zhang L, Morales M., Synapse. December 1, 2002; 46 (3): 150-6.
CB1 cannabinoid receptors in amphibian spinal cord: relationships with some nociception markers. , Salio C, Cottone E, Conrath M, Franzoni MF., J Chem Neuroanat. September 1, 2002; 24 (3): 153-62.
Relationships between CB1 cannabinoid receptors and pituitary endocrine cells in Xenopus laevis: an immunohistochemical study. , Cesa R, Guastalla A, Cottone E, Mackie K, Beltramo M, Franzoni MF., Gen Comp Endocrinol. January 1, 2002; 125 (1): 17-24.
Cannabinoid receptor CB1-like and glutamic acid decarboxylase-like immunoreactivities in the brain of Xenopus laevis. , Cesa R, Mackie K, Beltramo M, Franzoni MF., Cell Tissue Res. December 1, 2001; 306 (3): 391-8.
In-vitro and in-vivo action of cannabinoids. , Akinshola BE, Chakrabarti A, Onaivi ES., Neurochem Res. October 1, 1999; 24 (10): 1233-40.
Anandamide inhibition of recombinant AMPA receptor subunits in Xenopus oocytes is increased by forskolin and 8-bromo-cyclic AMP. , Akinshola BE, Taylor RE, Ogunseitan AB, Onaivi ES., Naunyn Schmiedebergs Arch Pharmacol. September 1, 1999; 360 (3): 242-8.
Unsaturated long-chain N-acyl-vanillyl-amides (N-AVAMs): vanilloid receptor ligands that inhibit anandamide-facilitated transport and bind to CB1 cannabinoid receptors. , Melck D, Bisogno T, De Petrocellis L, Chuang H, Julius D, Bifulco M, Di Marzo V., Biochem Biophys Res Commun. August 19, 1999; 262 (1): 275-84.
Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. , Zygmunt PM, Petersson J, Andersson DA, Chuang H, Sørgård M, Di Marzo V, Julius D, Högestätt ED., Nature. July 29, 1999; 400 (6743): 452-7.
Evaluation of the cannabinoid CB2 receptor-selective antagonist, SR144528: further evidence for cannabinoid CB2 receptor absence in the rat central nervous system. , Griffin G, Wray EJ, Tao Q , McAllister SD, Rorrer WK, Aung MM, Martin BR, Abood ME., Eur J Pharmacol. July 14, 1999; 377 (1): 117-25.
Distinct domains of the CB1 cannabinoid receptor mediate desensitization and internalization. , Jin W, Brown S, Roche JP, Hsieh C, Celver JP, Kovoor A, Chavkin C, Mackie K., J Neurosci. May 15, 1999; 19 (10): 3773-80.
Coupling of the expressed cannabinoid CB1 and CB2 receptors to phospholipase C and G protein-coupled inwardly rectifying K+ channels. , Ho BY, Uezono Y, Takada S, Takase I, Izumi F., Recept Channels. January 1, 1999; 6 (5): 363-74.
Cannabinoids inhibit N- and P/Q-type calcium channels in cultured rat hippocampal neurons. , Twitchell W, Brown S, Mackie K., J Neurophysiol. July 1, 1997; 78 (1): 43-50.